Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Nephrology Nursing Journal Editorial Board Statements of Disclosure: In accordance with ANCC governing rules Nephrology Nursing Journal Editorial Board statements of disclosure are published with each CNE offering. The statements of disclosure for this offering are published below.
Paula Dutka, MSN, RN, CNN, disclosed that she is a coordinator of Clinical Trials for the following sponsors: Amgen, Rockwell Medical, Keryx Biopharmaceuticals, Akebia Therapeutics, and Dynavax Technologies.
Norma J. Gomez, MBA, MSN, CNNe, disclosed that she is a member of the ZS Pharma Advisory Council.
Tamara M. Kear, PhD, RN, CNS, CNN, disclosed that she is a member of the ANNA Board of Directors, serves on the Scientific Advisory Board for Kibow Biotech, Inc., and is employed by Fresenius Kidney Care as an acute hemodialysis RN.
All other members of the Editorial Board had no actual or potential conflict of interest in relation to this continuing nursing education activity.
This article was reviewed and formatted for contact hour credit by Beth Ulrich, EdD, RN, FACHE, FAAN, Nephrology Nursing Journal Editor, and Sally Russell, MN, CMSRN, CPP, ANNA Education Director.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses Association – Provider is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
This CNE article meets the Nephrology Nursing Certification Commission’s (NNCC’s) continuing nursing education requirements for certification and recertification.
Learning Engagement Activity: For additional information in issues with women and kidney disease, please visit the session entitled “Pregnancy and the Patient with Chronic Kidney Disease” presented by Madeline Pahl, MD -Click Here! (Additional costs may be associated)
Learning Outcome: After completing this learning activity, the learner will be able to discuss World Kidney Day and International Women’s Day as awareness campaigns about women, kidney health, and kidney disease, and worldwide treatment improvement options.
Women and Kidney Disease: Reflections on World Kidney Day 2018
1.30 - CH
You must be logged in and own this product in order to post comments.
1/4/19 5:17 pm
1/8/19 7:07 pm
attempting to understand and digest material .
1/13/19 3:48 pm
Interesting article, leaving many doors open for additional research in multiple areas, including septic abortions, PE after assisted fertilization, as well as multiple other areas. Would be interested in additional follow-up.
1/21/19 9:00 am
Very interesting article that raises more questions than answers. Saved it to share with my colleagues in Women's health to discuss some of the issues raised regarding autoimmune diseases in pregnancy.
1/22/19 10:33 am
Enlightening article which made me more knowledgeable about pre-eclampsia being a risk factor in the future development of CKD.
1/22/19 2:39 pm
It is important to educate women who have high risk of morbidity related to ESRD.
1/31/19 2:21 pm
Lots of information about women and kidney disease. it is very interesting topic. I enjoyed reading it.